COUP-TFI
COUP-TFI (Chicken Ovalbumin Upstream Promoter-Transcription Factor I), also known as NR2F1, is a nuclear receptor that plays a crucial role in the regulation of gene expression during development and cell differentiation.
Function[edit]
COUP-TFI is a member of the nuclear receptor family of intracellular transcription factors. It is involved in the regulation of several biological processes, including neurogenesis, organogenesis, and metabolism. COUP-TFI functions by binding to specific DNA sequences known as response elements, thereby modulating the transcription of target genes.
Role in Development[edit]
During embryonic development, COUP-TFI is essential for the proper formation of the central nervous system and the peripheral nervous system. It regulates the expression of genes involved in neuronal differentiation and axon guidance. COUP-TFI is also implicated in the development of the cardiovascular system and the limbs.
Clinical Significance[edit]
Mutations or dysregulation of COUP-TFI have been associated with various developmental disorders and diseases. For instance, alterations in COUP-TFI expression have been linked to congenital heart defects, intellectual disability, and autism spectrum disorders.
Interactions[edit]
COUP-TFI interacts with other transcription factors and co-regulators to exert its effects on gene expression. It can form heterodimers with other nuclear receptors, such as RXR (Retinoid X Receptor), to enhance or repress the transcription of target genes.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which COUP-TFI regulates gene expression and its role in disease pathogenesis. Studies are also exploring the potential of targeting COUP-TFI for therapeutic interventions in diseases where its function is disrupted.
See Also[edit]
References[edit]
External Links[edit]
- [COUP-TFI at the US National Library of Medicine Medical Subject Headings (MeSH)]
- [NR2F1 gene information at NCBI]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian